FULL SUPPLEMENT: United States Cutaneous Oncodermatology Management (USCOM ) V: A Multidisciplinary-Guided Algorithm for Preventing and Managing Cutaneous Hormonal Therapy-Related Adverse Events in Cancer Patients
April 2025 | Volume 24 | Issue 4 | 84820s1 | Copyright © April 2025
Published online March 31, 2025
ET AL
Abstract
Although cancer incidence continues to rise, advancements in treatment options have contributed to the decline in cancer mortality.1,3 Hormonal therapy is a mainstay treatment for the management of hormone-dependent cancers. In breast cancer, hormonal therapy often involves reducing estrogen levels or blocking estrogen receptors. For prostate cancer, therapy typically aims to lower testosterone levels or block its effects through androgen deprivation therapy or antiandrogens.